South Africa Microfluidics Market Size & Outlook
South Africa microfluidics market, 2018-2030 (US$M)
Related Markets
South Africa microfluidics market highlights
- The South Africa microfluidics market generated a revenue of USD 229.9 million in 2023 and is expected to reach USD 507.8 million by 2030.
- The South Africa market is expected to grow at a CAGR of 12% from 2024 to 2030.
- In terms of segment, medical was the largest revenue generating technology in 2023.
- Medical is the most lucrative technology segment registering the fastest growth during the forecast period.
Microfluidics market data book summary
| Market revenue in 2023 | USD 229.9 million |
| Market revenue in 2030 | USD 507.8 million |
| Growth rate | 12% (CAGR from 2023 to 2030) |
| Largest segment | Medical |
| Fastest growing segment | Medical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Medical, Non-Medical |
| Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.7% of the global microfluidics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa microfluidics market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 507.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Microfluidics Market Scope
Microfluidics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa microfluidics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 84.12% in 2023. Horizon Databook has segmented the South Africa microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.
TB and HIV are the major issues in Africa. The province of KwaZulu-Natal has the highest HIV burden and TB is responsible for 14% of all deaths. To curb the prevalence of AIDs, Africa Health Research Institute is gathering researchers from different fields.
These experts would be used for developing cutting-edge solutions for HIV and training the next-generation African scientists. In July 2016, an interdisciplinary lab was formed through academic partnership between Howard Hughes Medical Institute, Well come Trust, and the University of KwaZulu-Natal.
The laboratory facility at K-RITH Tower Building is equipped with state-of-the-art biosafety labs, including those for microfluidic chips where scientists are working to develop low-cost diagnostic devices to tackle HIV and TB epidemic. South Africa is adapting to the changing dynamics of diagnostics industry with regard to microfluidics.
Reasons to subscribe to South Africa microfluidics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa microfluidics market databook
-
Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa microfluidics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa microfluidics market size, by technology, 2018-2030 (US$M)
South Africa Microfluidics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
